← All diseases Rare and hereditary disorders

Hereditary ATTR amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (80)Meta-analysis (11)Treatment guideline (1)Phase 3 study (30)Randomized trial (23)Systematic review (15)Clinical trial (344)Review article (146)Early study (phase 1 or 2) (7)Case report (135)Laboratory or animal study (8)Commentary or editorial (72) Studies currently recruiting participants only (35)

Filter

Publications and studies (1285)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis. (2023-01-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis. (2023-01-27) ♡
• Patisiran Enhances Muscle Mass after Nine Months of Treatment in ATTRv Amyloidosis: A Study with Bioelectrical Impedance Analysis and Handgrip Strength. (2022/12/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management. (2022/12/20) ♡
• A Metabolic Signature of Hereditary Transthyretin Amyloidosis: A Pilot Study. (2022/12/17) ♡
• Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications. (2022/12/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hereditary transthyretin amyloidosis overview. (2022/12/01) ♡
• A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS). (2022/12/01) ♡
• Population pharmacokinetic/pharmacodynamic modelling of eplontersen, an antisense oligonucleotide in development for transthyretin amyloidosis. (2022/12/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update. (2022/12/01) ♡
• Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis. (2022/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Cutaneous silent period in ATTRv carriers: a possible early marker of nerve damage? (2022/12/01) ♡
• Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy. (2022/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis. (2022/12/01) ♡
• Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver-directed drugs for transthyretin-mediated amyloidosis. (2022/12/01) ♡
• Overview of Current and Emerging Therapies for Amyloid Transthyretin Cardiomyopathy. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Care of Patients With Transthyretin Amyloidosis: the Roles of Nutrition, Supplements, Exercise, and Mental Health. (2022/12/01) ♡
• Small interfering RNA: potential applications for nephrologists Small interfering RNA: potential applications for nephrologists. (2022/12/01) ♡
• Trajectories of Kidney Function in Patients with ATTRv Treated with Gene Silencers. (2022/11/29) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Preimplantation genetic testing for familial amyloid polyneuropathy. (2022/11/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Vitreous amyloidosis caused by a Lys55Asn variant in transthyretin: A case report. (2022/11/16) ♡
• Suture trabeculotomy ab interno for secondary glaucoma in Japanese patients with Val30Met hereditary transthyretin amyloidosis. (2022/11/11) ♡
• Quantitative Sensory Testing in Late-Onset ATTRv Presymptomatic Subjects: A Single Center Experience. (2022/11/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. (2022/11/05) ♡
• Early transverse tubule involvement in cardiomyocytes in hereditary transthyretin amyloidosis: a possible cause of cardiac events. (2022/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pitfalls of cubital electrical nerve stimulation for neuromuscular transmission monitoring: A case report of familial amyloid polyneuropathy. (2022/11/01) ♡
• Treating Transthyretin Amyloidosis via Adeno-Associated Virus Vector Delivery of Meganucleases. (2022/11/01) ♡
• Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. (2022/10/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multidisciplinary amyloidosis care in the era of personalized medicine. (2022/10/13) ♡
• Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation. (2022/10/12) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Long-term treatment effects of inotersen on health-related quality of life in patients with hATTR amyloidosis with polyneuropathy: Analysis of the open-label extension of the NEURO-TTR trial. (2022/10/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hereditary Transthyretin Amyloidosis Cardiomyopathy: The South Florida Experience. (2022/10/01) ♡
• Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis. (2022/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Genotype-Phenotype Correlation of a Rare Transthyretin Variant Causing Amyloidosis. (2022/10/01) ♡
• Application of optical coherence tomography angiography to assess systemic severity in patients with hereditary transthyretin amyloidosis. (2022/09/26) ♡
• Establishing Occupational Therapy Needs: A Semi-Structured Interview with Hereditary Transthyretin Amyloidosis Patients. (2022/09/17) ♡
• Magnetic resonance imaging of dorsal root ganglion in a pre-symptomatic subject with familial amyloid polyneuropathy transthyretin E61K. (2022/09/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China. (2022/09/02) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The Value of Nerve Biopsy in Transthyretin Amyloidosis with Competing Comorbidities. (2022/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeted treatments of AL and ATTR amyloidosis. (2022/09/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis. (2022/09/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Factors associated with increased health-related quality-of-life benefits in hereditary transthyretin amyloidosis polyneuropathy patients treated with inotersen. (2022/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac amyloidosis: State of art in 2022. (2022/09/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Transthyretin amyloidosis: the picture is getting clearer. (2022/09/01) ♡
• Cardiomyopathy correlates to nerve damage in p.A117S late-onset transthyretin amyloid polyneuropathy. (2022/09/01) ♡
• Ten questions about transthyretin amyloidosis. (2022/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Late-onset hereditary transthyretin amyloidosis with polyneuropathy. Report of one case]. (2022/09/01) ♡
• Corrigendum: Clinical 3-D gait assessment of patients with polyneuropathy associated with hereditary transthyretin amyloidosis. (2022/08/17) ♡
• Popeye's sign and transthyretin amyloidosis. (2022/08/14) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.